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Abstract
3D bioprinting has begun to show great promise in advancing the development of functional 
tissue/organ replacements. However, to realize the true potential of 3D bioprinted tissues for 
clinical use requires the fabrication of an interconnected and effective vascular network. Solving 
this challenge is critical, as human tissue relies on an adequate network of blood vessels to 
transport oxygen, nutrients, other chemicals, biological factors and waste, in and out of the tissue. 
Here, we have successfully designed and printed a series of novel 3D bone scaffolds with both 
bone formation supporting structures and highly interconnected 3D microvascular mimicking 
channels, for efficient and enhanced osteogenic bone regeneration as well as vascular cell growth. 
Using a chemical functionalization process, we have conjugated our samples with nano 
hydroxyapatite (nHA), for the creation of novel micro and nano featured devices for vascularized 
bone growth. We evaluated our scaffolds with mechanical testing, hydrodynamic measurements 
and in vitro human mesenchymal stem cell (hMSC) adhesion (4 h), proliferation (1, 3 and 5 d) and 
osteogenic differentiation (1, 2 and 3 weeks). These tests confirmed bone-like physical properties 
and vascular-like flow profiles, as well as demonstrated enhanced hMSC adhesion, proliferation 
and osteogenic differentiation. Additional in vitro experiments with human umbilical vein 
endothelial cells also demonstrated improved vascular cell growth, migration and organization on 
micro-nano featured scaffolds.
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1. Introduction
In recent years, 3D printing has become a popular and widely investigated method for the 
fabrication of large bone implants [1, 2]. 3D printed bone constructs, devices and treatments 
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hold great potential to repair traumatic and chronic injuries, restore tissue shape and function 
and return those afflicted with diseases and traumatic injury to large portions of bone (such 
as craniofacial and maxillofacial trauma) to normal, and even fully functional lives [3, 4]. 
Current work in academia has been very successful in applying 3D printing to design load 
bearing, patient specific and even to some degree bioactive bone constructs [5–10], but they 
have been limited in their ability to translate to clinically usable implants [11–13]. One of 
the most pressing reasons is that large and highly functioning areas of damaged bone, so 
called ‘critical defects,’ require an interconnected and effective vascular network [14, 15]. A 
dramatic example of such an injury would be someone who had severe damage to their skull 
and face, resulting from a car accident. But the need to grow large volumes of bone tissue 
can also extend to limb and total joint reconstruction, and is the sort of technology which 
would one day help to replace artificial limbs, orthotics and total joint replacement surgery. 
Solving this challenge is critical, as bone relies on an adequate network of blood vessels to 
transport waste, nutrients, growth factors and other chemicals and biological factors in and 
out of the tissue [14, 16, 17]. Bone tissue engineering has a specific need to solve this 
critical issue [18–23].
Today in the field nanostructured materials have already been popular for growth of blood 
vessels and biomimetic vascular networks to further enhance tissue growth [24–30]. 
Specifically, bone has been targeted as a model system for some of these studies. Sun et al 
modeled vascularized bone regeneration within a biodegradable nanoporous calcium 
phosphate scaffold loaded with growth factors [24]. Midha et al employed bioactive 
nanofeatured glass foam scaffolds to grow osteoblasts and vascular cells in vitro [25]. Both 
of these examples show how nanostructured materials can be used to effectively entice 
vascularized bone growth. On the opposite end, there are also benefits to designing larger 
support structures on the micro to macro scale which can initially support the functional 
aspects of vascularized bone, before and during new tissue formation. The ability to create 
highly ordered and interconnected anisotropic nano to micro to macro structures becomes 
especially important when designing multi-tissue systems, such as a vascular network 
growing throughout bone [26].
To this end, researchers have begun using 3D printing to create advanced macro-scale bone 
replacement implants and to create efficient, bioactive microfeatured networks [31–34]. 
Temple et al designed and produced anatomically shaped vascularized bone grafts with 
human adipose-derived stem cells and 3D-printed polycaprolactone scaffolds [4]. This 
demonstrated 3D printing’s ability to create devices for vascularized bone formation. 
However, there has been limited success thus far to print scaffold designs on the nanoscale 
[35, 36]. Combining nanostructured materials with micro and macro scaled 3D printing may 
hold the key to producing large yet fully functional and bioactive regenerative bone 
scaffolds, implants and devices.
Here we have combined nanomaterials and 3D printing for a highly innovative complex 3D 
printed scaffold with both nano and micro features for both bone and vascular growth. Key 
innovations of this project include the design and fabrication of a fully interconnected 3D 
fluid perfusable micro-channel network, within a microstructured bone forming matrix. Also 
in this study we designed and achieved a unique integration of nanocrystalline 
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hydroxyapatite (nHA) into our 3D printed scaffolds using a post fabrication process. We 
incorporated hydrodynamic measurement of unsteady pressure and flow rates. These 
measurements facilitate a preliminary understanding of the causal effects of predesigned 
structure-induced flow perturbations and the efficacy of such structures. Our motivation to 
study arterial blood flow in context of predesigned vascular structures is due to the essential 
role of blood supply for the growth of large critical-sized bone tissue. We envisioned that 
vascular network in the 3D printed scaffolds would experience flow conditions with some 
intrinsic vascular flow features such as flow rates, pressures and pulsatility. We therefore, 
modeled the hydrodynamic experiments under similar flow conditions in an exclusive 
arterial flow loop, recreating those salient cardiovascular flow characteristics. Ultimately, we 
believe that vascular flow properties and pulsatility may have a greater role to play toward 
fast, in situ delivery of blood, nutrients, progenitors and growth factors through our 
predesigned vascular structures. Cellular study was also conducted to prove scaffolds’ 
effectiveness in enhancing cell growth and tissue formation, and physical characterization 
was performed to show desirable, bone like characteristics.
2. Methods
2.1. Scaffold design and 3D printing
Overall, we envision a novel strategy and efficacy for our designed scaffolds. Large 
microchannles (compared to smaller bone matrix microstructures) are intended to facilitate 
rapid blood diffusion throughout the scaffolds. This may be accomplished by exposure to 
blood or grafting of an adjacent arterial vessel during implantation. The purpose is to 
provide rapid and fully penetrating supplies of blood, nutrients and most importantly 
autologous cells in situ.
Figure 1 shows a flow chart of the overall experimental design. The scaffolds’ outer shape 
was a 7.5 mm diameter and a 5 mm high cylinder. For the bone region, the scaffolds had a 
250 μm diameter hexagonal pore size and a 375 μm layer height. The pores in the bone 
regions were closely packed and then stacked layer by layer, as opposed to the fluid flow 
microchannel networks which were long interconnected channels. In order to further 
dampen fluid perfusion through the bone matrix, and provide a more biomimetic network for 
microvascular vasculature to develop on, we sought to provide a disrupted, yet highly 
directionalized flow path perpendicular to the vertical alignment of the hexagonal pores 
through the scaffolds’ pore structures by alternating the scaffold geometry between a simple 
line pattern and a hexagonal pore pattern. That is to say, the first layer of scaffold pore 
structure was an arrangement of interlocking hexagons in the X–Y plane, while moving up 
another full layer in the Z-direction the pore structure changes to a simple series of aligned 
struts. This pattern then alternates between hexagons and struts with each layer.
The mechanism of pore geometry on cell development has been recently shown to be a 
product of the total pore perimeter size, rather than the explicit pore shape [37]. Still, the 
‘hexagonal shape’ as it is realized here may provide an opportunity to create 3D printed 
hexagonal pores that are smaller than the smallest printable square pores. Within this bone 
matrix, a series of interconnected horizontal and vertical channels were designed, in order to 
provide a fast and efficient perfusion of arterial blood throughout the scaffold architecture 
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(figures 2(A)–(G)). The ‘bone’ region porosity is shown in gray, while the microchannels are 
outlined in red. In our designs the channel diameter was also varied between a 500 and a 250 
μm radius. All scaffold 3D models were then saved as stl files and processed using the Sli3er 
software package and saved as gcodes. They were then subsequently printed from polylactic 
acid (PLA) on a Solidoodle fused deposition modeling printer in a layer by layer fashion 
using the Pronterface software controller interface. Additionally, representative CAD models 
of the scaffolds’ porosity were made using Rhino, and then analyzed for surface area, 
volume, and pore density.
2.2. nHA synthesis and aminolysis functionalization
After initial 3D fabrication, scaffolds were additionally modified with a nHA conjugation. 
nHA was first synthesized using a wet chemistry procedure and a hydrothermal process, as 
thoroughly described in our previous studies [38, 39]. Then, nHA particles were conjugated 
onto scaffolds using a process described by Aishwarya et al [40] and our previous study 
[41]. First, PLA scaffolds were aminolysed. This was achieved by immersing them in an 
ethylenediamine/n-propanol (1:9 ratio) solution at 60 °C for 5 min. Scaffolds were then 
extensively washed with deionized water and dried at 35 °C. This results in the presence of 
an NH2 amine group on the PLA substrate. The aminolysed scaffolds were then immersed in 
a 1% gluteraldehyde solution at room temperature for 3 h to conjugate CHO functional 
groups onto the NH2 groups. After washing extensively, scaffolds were immersed in a 
solution of 10% w/v nHA at 4 °C for 24 h. The process itself yields a series of layered 
chemical attachments, which includes an NH2 amino group attached to the PLA, CHO 
functional groups formed off of the amines and finally nHA conjugated on the CHO 
functional groups.
2.3. Mechanical testing and scaffold characterization
Five scaffolds from both microchannel groups were tested. Scaffolds were tested using a 
Lucas Scientific FLS-I portable mechanical tester. A 3 cm compression platen was fitted to 
the advancing end of the piston, and scaffolds were compressed at a strain rate of 0.1 cm 
min−1, until failure. Data was collected and analyzed in Excel. The slope of the linear elastic 
region of each sample’s produced stress strain graph was calculated in order to find the 
Young’s Modulus. Samples were imaged using a Zeiss SigmaVP scanning electron 
microscope (SEM). Scaffolds were coated with a roughly 10 nm thick conductive gold layer 
using a gold sputter coater. Scaffolds were then imaged using 3.65 kV electron beam. 
Additionally, scaffold which were not coated with gold were mounted on carbon tape and 
analyzed using an Oxford instruments energy dispersive x-ray (EDX) spectroscope, in order 
to characterize the elemental composition present on scaffolds’ surfaces.
2.4. Hydrodynamic measurements of flow rate and pressure
Hydrodynamic experiments and data collection were performed using a custom made, 180° 
curved artery test section (with curvature ratio, r/R = 1/7) setup designed to represent a 
dynamically similar pulsatile arterial blood flow through a single arterial vessel [42–46]. 
The closed loop experimental setup shown in figure 3, consists of a fluid reservoir, inlet and 
outlet pipes, a programmable pump and a 180° curved tube test section. The inlet and outlet 
pipes are made of acrylic and approximately, 2 m long and are connected to a removable 
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180° curved test section. A Newtonian blood-analog fluid is supplied using a programmable 
pump (ISMATEC BVP-Z) to tubes containing the scaled model-scaffolds. The inflow 
conditions are based on a carotid artery-based digitized flow rate waveform reported in a 
paper by Holdsworth et al [47]. The composition of the Newtonian blood-analog fluid used 
in experiments is 40% glycerine and 60% deionized water (by weight). The kinematic 
viscosity of 3.4449 (±0.071 246) mm2 s−1 was measured using a standard Ubelhoode 
viscometer and density (1.078 g ml−1) at approximately 27 °C (ambient room temperature) 
[42–46].
2.5. In vitro study
hMSCs were obtained from the Texas A&M Health Science Center, Institute for 
Regenerative Medicine, and were expanded originally from a donor source. Additionally, 
human umbilical vein endothelial cells (HUVECs) were purchased from Life Technologies. 
All hMSC studies were cultured in complete cell media (CCM) consisting of alpha 
minimum essential medium, 16% fetal bovine serum, 1% L-glutamine, and 10 μg ml−1 of 
ciprofloxacin. hMSC osteogenic differentiation studies were cultured in CCM supplemented 
with 50 μg ml−1 L-ascorbate acid (Sigma) and 10 mM β-glycerophosphate (Sigma). 
HUVECs were cultured in endothelial growth media consisting of medium 200 and 2% low 
serum growth supplement both purchased from Life Technologies. hMSC and HUVEC in 
vitro studies on our constructs were conducted as follows.
For hMSC and HUVEC adhesion, printed bone scaffolds were seeded with 50 000 cells per 
scaffold. Sample groups included scaffolds with large and small microchannels, and 
scaffolds with large and small microchannels conjugated with nHA. Samples were cultured 
in 24 well plates for 4 h, and then transferred to new well plates, washed twice with 
phosphate buffered solution (1X) and trypsinized with 0.25% trypsin EDTA in an incubator 
for 6 min. This time period was decreased for HUVECs to 3 min, at room temperature. 
Suspensions were then alloquated into a 96 well plate. 100 μl of each sample suspension 
were reacted with a molecular probes MTS cell counting reagent and incubated at 37 °C for 
1 h. Samples were then read on a Thermo Scientific Multiskan GO photometric plate reader 
at 490 nm. hMSC and HUVEC proliferation was conducted at 1, 3 and 5 d. Samples were 
seeded with 55 000 cells per scaffold, cultured in CCM and counted at each time point using 
the same MTS assay described above.
hMSC differentiation studies were seeded with 125 000 cells per scaffold and cultured for 
three weeks. At the end of each week, samples were taken from each experimental group 
and digested via a papain digestion protocol consisting of a PBS wash, freezing in a −80 °C 
freezer and drying overnight in a lyophilizer. Samples were then immersed in 500 μl papain 
and incubated at 60 °C for 24 h. Samples once digested were tested for calcium and collagen 
type I deposition. A calcium detection kit was used to test samples for calcium deposition. 
200 μl of suspension were removed from each sample, transferred to a 96 well plate and 
reacted with a dye reagent, after being reacted with an acidic calcium dissociation reagent. 
Once the reaction was complete, samples were read on a photometric plate reader at a 
detection wavelength of 560 nm. A collagen type I ELISA immunochemistry assay was used 
to measure collagen type I content. 50 μl of solution from each sample were transferred to a 
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96 well plate, washed with a dissociation reagent, and transferred to a 96 well plate coated 
with capture antibodies (standard ELISA assay wellplate). After incubation at 37 °C, 
samples remaining solutions was removed from the wells, and they were washed. A second 
dye-bound antibody was transferred to the wells, and the plate was incubated at 37 °C. The 
wells were then emptied, washed, and a dissociation reagent was added. Samples were then 
read on a photometric plate reader at a 490 nm detection wavelength.
2.6. Confocal microscopy
Fluorescent labeling and confocal imaging were also used to further characterize hMSC 
spreading and morphology on our constructs. Special 0.5 mm thick scaffolds were fabricated 
and then seeded with 500 000 hMSCs cells per scaffold. Samples were taken at 1, 3 and 5 d, 
fixed in formalin for 15 min and treated with 0.1% Triton-X for 15 min to permeate the cell 
membrane. Samples were then stained with Texas Red- phalloidin for 15 min and stained 
with DAPI for 10 min. Samples were viewed on a Zeiss 710 confocal microscope. HUVECs 
were also seeded, cultured and imaged, similar to the protocol above. They were also stained 
with a Texas Red—phalloidin preparation which was a 1:40 concentration of dye methanol 
stock to PBS, as opposed to a 1:200 dilution used for hMSC staining. This was to ensure that 
the HUVECs, which are smaller and grow in less dense groups that hMSCs, were 
completely stained and visible. In order to jump start angiogenesis, the printed samples were 
further treated with a 100 ng ml−1 concentration of human vascular endothelial growth factor 
(VEGF121, a highly effective and proven growth factor responsibly for new vessel formation 
[48, 49]) at 37 °C for 24 h, prior to cell culture. Additionally, once angiogenesis starts, cells 
growing in the microenvironment often continually express VEGF as new blood vessels are 
forming [50–52], which is why we chose not to include it as an additive in the cell media.
2.7. Statistics
All quantitative material testing and cellular studies were conducted with either a sample 
size of n = 3 or three repeated experiments with total samples size of n = 9 per group for 
each time point, respectively. All quantitative data was compared using a student’s t-test, 
with a p value less than 0.05 taken as ‘statistically significant.’
3. Results
3.1. Characterization of 3D printed bone scaffold with fluid perfusable microchannel 
network
SEM imaging (figures 4(A)–(D) showed that we were able to print vertical microchannels, 
within a porous bone matrix, with both a 500 and 250 μm radius. In addition, SEM imaging 
of partially printed scaffolds showed the successful fabrication of aligned and interconnected 
horizontal channels. Once PLA 3D printed scaffolds were fabricated, they were 
subsequently chemically conjugated with nHA. Scaffolds with nHA were imaged via SEM 
at high resolution (figures 4(E) and (F)). In addition, figure 4(G) shows a spectrograph of the 
elemental analysis obtained from EDX. The graph clearly shows the presence of peaks 
consistent with and identified by the instrument’s analysis software as Calcium. Table 1 
shows physical attributes calculated using Rhino and Excel, and compares them to values 
computed from measured scaffold dimensions take from SEM images. The table 
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demonstrates that we could print scaffolds to within tens of microns of the designed 
microstructural measurements, and thus achieve relatively comparable physical scaffolds 
characteristics. It also shows that we were able to effectively change the channel diameter, 
while keeping the porosity and surface area to volume ratio fairly constant.
Mechanical testing data demonstrated that scaffolds printed with PLA in our predesigned 
vascularized bone microstructures could withstand normal mechanical loading, and 
exhibited typical elastic behavior (figure 5). The Young’s Modulus of scaffolds printed with 
smaller microchannels was 51% higher than those printed with larger channels. While both 
scaffolds performed within the regime less than normal cortical bone in compression (10–50 
GPa) [53–55], they still fall within the range of recorded failure regimes of bone under 
impact loading [56, 57]. The behavior of a material when more void space, (i.e. larger 
confined spaces with no material or structure present) is introduced suggests that the 
scaffolds with larger channels would in fact have diminished mechanical properties [53].
3.2. Hydrodynamic flow characterization of scaled-microchannels
Scaffold models that were scaled to match the hydrodynamic measurement-setup (figure 3) 
were subjected to pulsatile, carotid artery-based inflow conditions. The pulsatile inflow 
waveforms were scaled using dynamic similarity to a time period (T) of 4 s, while 
maintaining the signal harmonics and minimization of Gibbs-type phenomenon using a data 
acquisition card (NI-USB6229). Details of experimental inflow conditions and parameters 
such as mean and maximum Reynolds numbers, pulsation harmonics, dynamic scaling can 
be found in papers by Glenn et al [45, 46] Bulusu and Plesniak [42–44], The mean and 
maximum Reynolds numbers maintained at the same level as the waveform reported in the 
paper by Holdsworth et al [47].
The pressure and flow rate associated with the inflow waveform were measured using a 
pressure catheter with an optimally damped MEMS cantilever (Transonic Scisence™) and an 
ultrasonic flow rate sensor (Transonic ME12PXL), respectively. The location of these 
sensors are shown in figure 3.
One hundred cycles of pressure and flow rate were measured to generate a statistically 
relevant data ensemble at 250 Hz (sampling frequency i.e., 1000 waveform instances 
acquired over a 4 s time period, T). The data collected from one hundred measurement 
cycles was adequate for the production of phase averaged pressure and flow rate. Pressure 
and flow rate could then be used for phase-shift related discussions. MATLAB™ was used 
for all data processing, as described above.
In order to investigate the fluid flow behavior of different diameter channels, a ‘clean artery-
control case’ (vessel with no construct) and two scaled up models representing an isolated 
section of the scaffolds’ scaled-microchannel network were designed using Rhino, and 3D 
printed on a Stratasys Objet24 Desktop 3D printer (figure 6(A)). These constructs were then 
inserted into the system detailed above (figure 6(B)) at two locations from the 180° curved 
tube test section, viz., at the inlet of the 180° curved tube test section and in the straight inlet 
pipe away from the 180° curved tube test section.
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Self-normalized pressure and flow rate data plotted against the dimensionless time (0 ≤ t/T ≤ 
1) are shown in figures 7(A)–(E) to enable a direct comparison for temporal, pressure and 
flow rate variations and, phase shifts. The measured waveforms downstream from the test 
section showed a flow rate and pressure signals with phase shifts or delays that progressively 
increase during on full cycle of the inflow waveform. This pressure-flowrate delay or phase 
shift is representative of blood flow in vessels without any obfuscations such as stenoses and 
prosthetics such as stents or scaffolds and accordingly, we called it the clean artery-control 
case. The results of our measurements are further divided into five cases by the type of 
channel and location as shown in figures 7(A)–(E); This phase-shift phenomenon generally, 
can be seen with the constructs were placed at two locations (proximity to and away from 
the test section) and is pronounced after the peak of the waveforms (known as systolic peak) 
and during the deceleration phase. The flow rate and pressure waveforms for the large and 
small diameter scaled-microchannels demonstrated subtle, but observable phase-shifts 
(between 0.18 ≤ t/T ≤ 0.3). The measurements though preliminary, revealed that despite the 
presence of the constructs there is minimal variation in pressure-flow rate phase-shifts in 
comparison with the control case.
3.3. Enhanced hMSC and HUVEC growth and development in 3D printed nHA conjugated 
microstructured bone constructs
Initial adhesion studies showed that after 4 h, hMSC cellular adhesion decreased on 
scaffolds without nHA when the size of the microchannels decreased (figure 8(A)). After 
adding nHA, small channel scaffolds were 4.6% more adherent than the scaffolds with the 
least number of adhered cells (small channels with no nHA). Proliferation studies yielded 
increases at 1 and 3 d (figure 8(B)). After 5 d of culture, scaffold with small microchannels 
and nHA had the highest cell number, with a 39% increase compared to the large micro-
channel scaffold with no nHA, and a 51% increase when compared to the scaffolds with 
large microchannels and nHA.
We performed further confocal imaging experiments on hMSCs proliferating on our 
scaffolds for 5 d (figure 9). After only 1 d of culture, hMSCs formed dense and evenly 
distributed networks of aligned cells on all scaffolds. On scaffolds with 250 μm 
microchannels, cells formed cell aggregates, which appeared to have more dense and aligned 
morphologies. These effects were in turn greatly enhanced on scaffolds that were conjugated 
with nHA. Additional increased cell growth and enhanced arrangement could be seen on 
nHA conjugated scaffolds with 250 μm micro-channels over 3 and 5 d of culture.
HUVEC in vitro evaluation showed that our scaffolds are also effective in supporting and 
enhancing vascular cell growth and activity. 4 h HUVEC adhesion demonstrated that 
HUVEC cells adhere the best on scaffolds with small channel diameters and nHA (figure 
10(A)). Specifically, the small microchannel scaffold with nHA had a 43.7% greater cell 
count than the least performing scaffold. HUVEC 5 day proliferation showed increases in 
cell number at 1, 3 and 5 d (figure 10(B)), with the greatest increase on the scaffolds without 
nHA and with large microchannels, which was a staggering 201% greater when compared to 
the least performing group (small nHA conjugated). Confocal imaging of cultured HUVECs 
(figure 11) showed HUVECs adhering and growing of scaffolds after 1, 3 and 5 d. After 1 d, 
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dense cellular aggregates can be observed on the large channel scaffolds, and some appear to 
be forming long micro-tubular vessels aligned with the scaffold’s geometry. Scaffolds with 
smaller channels have less present cell populations, but exhibited similar morphology. 
Scaffolds with nHA and VEGF did not show the same sort of high cellular activity, 
specifically with regard to the formation of long, continuous, interconnected vascular tubes. 
Additionally, a strong fluorescent background signal from the nHA modification made it 
difficult to accurately assess total HUVEC morphology. But, due to observable cell nuclei, 
cells attaching and forming zig-zag patterns could be observed on the actual surface of 
scaffold features. At 3 and 5 d, cell aggregates broke up and HUVECs continued to form 
long vascular structures and networks along the features of the large channels scaffolds. 
Comparatively, cells continued to form zig-zagging cellular arrangements and denser 
aggregates on the scaffolds with small channels, conjugated with nHA and a pre culture 
VEGF treatment.
hMSC osteogenic differentiation study results are shown in figures 12(A) and (B). Collagen 
type I synthesis (figure 12(A)) was significantly increased on scaffolds with nHA, as 
compared to those without, after 1 week. Additionally, all scaffolds increased after three 
weeks, with the greatest increase being on the scaffolds with small channels and nHA. 
Specifically, scaffolds with small microchannels and nHA showed a 13% increase over 
scaffolds with large microchannels and no nHA conjugation. Additional calcium deposition 
(figure 12(B)) increased in calcium on all scaffolds, and the greatest calcium increase being 
on the scaffolds with nHA and smaller microchannels. There was an increase in calcium 
deposition from the large channels design to the small channel scaffold. At 2 and 3 weeks of 
culture, calcium deposition on small channel scaffolds with nHA was greatly enhanced. 
These scaffolds had a 391% increase over scaffolds with large channels and no nHA. After 3 
weeks both scaffold with nHA had similar calcium content and overall was the dominant 
factor in upregulating calcium deposition after longer periods of time. However, at two 
weeks the scaffolds with small channels and nHA were the only scaffold to show significant 
calcium deposition, demonstrating the ability of smaller channels to entice earlier calcium 
deposition upregulation.
4. Discussion
4.1. Biomimetic physical and hydrodynamic properties on 3D printed scaffolds
In this study, a series of well-defined microfeatured bone scaffold were printed, within the 
well-established resolution for 3D printing [58–60]. Post fabrication nHA was readily and 
effectively applied to our scaffolds using a aminolysis based conjugation process [41]. This 
allowed us to effectively create a highly novel micro and nano featured scaffold for 
enhanced bone and vascular cell growth. Our scaffolds also performed in compression, 
comparably to natural bone [53, 54, 61]. These results showed that as the size of blood 
vessel microchannels was decreased, the Young’s Modulus increased. However, this is due 
to the reduction of void space in the scaffold structure, and this is a well-known structural 
phenomenon in material science and solid mechanics [41, 53, 62]. All of these results 
demonstrate very plainly that we were able to design and fabricate scaffolds to highly 
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specified and bone-like characteristics, and these scaffolds then exhibited bone-like physical, 
particularly mechanical, properties.
As previously discussed, a blood supply is essential for the growth of large critical sized 
bone tissue. Some researchers in the field have begun utilizing flow perfusion bioreactors, to 
influence different cell types to form highly structured, micro-vascularized bone [63, 64]. 
But, these methods rely on extensive in vitro or ex vivo culture of tissues before they can be 
theoretically used clinically. Therefore, it is highly clinically relevant to design a scaffold, 
implant or orthopedic regenerative construct for vascularized, critical sized bone defects 
which can quickly and efficiently generate an arterial blood flow throughout. This would 
allow for fast in situ delivery of blood, nutrients, progenitors and growth factors either 
through fluid perfusion or arterial grafting to the implant. The supply of pulsatile arterial 
blood through the proposed microchannels would then diffuse through the smaller, more 
biomimetic porous matrix, allowing for the development of vascularized bone tissue. Thus, 
we sought to evaluate preliminary hydrodynamic performance through our scaffold designs, 
to get a better idea of scaffold performance with regard to this desired effect on blood flow 
and body fluid introduction. The experimental setup shown in figure 3, has been successfully 
used for cardiovascular flow diagnostics under stenotic and stent-implanted conditions that 
are believed to occur in physiological and clinical environments [42–44]. We performed 
preliminary hydrodynamic measurements of pulsatile pressure and flow rates in this setup 
and compared them to a control case (see figures 7(A)–(E)). We hypothesize that 
microvascular mimicking structures that maintain temporal, pressure-flow rate phase shifts 
as those characterized in native blood vessels would constitute an effectively designed 
structure.
The pressure and flow rate waveforms have similar temporal profiles such as characteristic 
systolic and diastolic phases and intrinsic phase shifts or time delays. These phase shifts are 
certain instances very subtle and sensitive to the scaffold location; compare perforated lines 
in figures 7(B)–(E). The scaled-channel designed structures, having large and small channels 
exhibited this phase shifting phenomenon, in a manner highly comparable and correlated to 
the clean artery –control case. This observation suggests that hydrodynamics of the designed 
micro-vessels may have the same characteristics as the control case representing native 
vessels with arterial blood flow. Accordingly, such designed structures may provide efficient 
and adequate blood and fluid transport in and out of the scaffold, without causing any flow 
disruptions to the system. Our future studies will rigorously evaluate these insights.
In summary, the hydrodynamic measurements have led to the integration of flow diagnostics 
with microchannel structure designs and have provided the means to evaluate the efficacy of 
vascularized bone constructs. The main implication of these measurements is that 
microchannel structures can be designed to generate flow characteristics that are highly 
correlated to native vascular systems, and may profile effective flow fluid perfusion and 
blood flow.
4.2. Enhanced cellular response and bone formation
Our scaffolds exhibited excellent performance during all hMSC study, and greatly enhanced 
both calcium and collagen type I synthesis during hMSC osteogenic differentiation. 
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Specifically, scaffolds with smaller channels and nHA performed the best. Since these 
scaffolds had physical and chemical properties most closely associated with native 
vascularized bone, we expected them to elicit the most bone formation and osteogenic 
differentiation [26, 65, 66]. Specifically this was due in part to adequate, yet more 
physiologically comparable fluid transfer, mechanical properties and both chemical and 
nanostructural contributions of the nHA. There was a slight decrease in collagen type I 
deposition on nHA scaffolds after 2 weeks of culture, but collagen type I content increased 
again after 3 weeks This may have been due to enhanced cellular migration on nHA 
conjugated scaffolds, as initial cellular migration and invasion has been shown to suppress 
both proliferation and tissue deposition, temporarily [41, 67–69].
HUVEC adhesion showed good initial attachment on scaffold with small channels and 
conjugated nHA. However, 5 d proliferation, while showing good increase in cell number on 
all scaffolds, had a large spike on the large channel scaffolds without nHA after 5 d. When 
these scaffolds were imaged with a confocal microscope, they also showed the greatest 
density of cells, and the most developed vascular structures. This may have been for several 
reasons. All vascular endothelial cell types rely heavily on fluid flow and shear stresses to 
migrate, grow, and align to form new tissue [70, 71]. And while they also may leverage 
structural cues for growth, this is a dominant factor in development. Our scaffolds were 
cultured in static conditions, which may show different cell growth and vascular formation 
behavior, as compared to fluid flow conditions (such as in a bioreactor) [72, 73]. However, it 
is important to consider a static condition, since our constructs would be initially implanted 
into a large bone defect, and not directly into blood vessels with available pumping arterial 
blood. The increased access to nutrients and chemicals in culture, and the potential for 
convective fluid mixing in scaffolds with larger microchannel spaces may have contributed 
to micro-shears in the fluid environment which could have effected cell growth [74]. 
HUVECs are also a very potent cell type [72, 73], and the presence of a softer substrate (no 
nHA) for cell attachment and more free space may have caused a high amount of HUVECs 
to grow more rapidly.
According to confocal imaging, all scaffolds showed highly enhanced hMSC attachment and 
spreading. 3D printed scaffolds displayed well integrated and highly aligned cell growth, 
displaying the effectiveness of these scaffolds to promote cellular organization. A decrease 
in size of our microchannels had denser, even more highly aligned cellular aggregates. 
Continued culture on scaffolds with small channels and conjugated nHA displayed 
increasing cell density, as well as larger and more spread cytoskeletons and filopodia. 
HUVECs which were also cultured on scaffold with small channels and nHA developed well 
after 5 d. Cells grew in dense, at times zig-zagging arrangements across scaffold features’ 
surfaces. Despite the fact that larger, longer and more highly developed vascular structures 
could be seen on pure PLA scaffolds with large diameter channel networks, vascular growth 
was mostly only observed in the 3D printed channels, pores and between scaffolds features, 
whereas HUVECs could be seen growing on the full surface of nHA conjugated scaffolds. 
This demonstrated that nHA conjugated scaffold could direct efficient and effective growth 
and development within 3D printed structures.
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In this project, a new, detailed construct for bone and vascular development was designed 
and validated. This design relies on complex, anisotropic structures designed to support 
hMSC osteogenic differentiation and bone formation, as well as vascular cell growth. In 
addition, nHA was successfully conjugated onto scaffolds post fabrication, for a highly 
novel combination of both bone and biomimetic microchannel structures, and osteogenic 
nanofeatures. Scaffolds had physical properties comparable to bone fracture regimes, and 
flow measurements revealed that the designed microchannels had similar flow 
characteristics to native blood vessels. Enhanced hMSC adhesion and growth were observed 
on scaffolds with small microchannels and nHA modification while scaffolds with large 
channels promoted the greatest HUVEC growth. MSC osteogenic differentiation study 
indicates our 3D printed scaffolds have excellent bone forming potential, based on collagen 
type I and calcium content. When all of the evaluated factors are taken into account, 
scaffolds with both large and small microchannels and nHA may provide a powerful 
construct for further in vitro experiments where multiple cell types are co-cultured, or for 
future in vivo study.
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Flow chart showing the overall experimental design.
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3D CAD modeling of scaffolds with (A), (C), (E) 500 μm microchannels and (B), (D), (F) 
250 μm microchannels. (G) illustrates the flow patterns in the microchannels of the designed 
scaffolds.
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Image and schematic illustration of experimental pulsatile flow setup. The black arrows 
represent the upstream fluid flow, or fluid being moved through the system and to the test 
section. The gray arrows represent the downstream flow, or fluid moving past the test section 
and returning through the system to the fluid reservoir.
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SEM images of 500 μm (A) vertical and (B) horizontal channels, and 250 μm (C) vertical 
and (D) horizontal pores, (E) low magnification and (F) high magnification SEM images of 
the surface of a nHA conjugated PLA 3D printed scaffold. (G) EDX analysis of the nHA 
modified scaffold.
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Young’s modulus of mechanically compressed scaffolds, Data are mean ± standard error of 
the mean, n = 5; *p < 0.05 when compared to large vascular mimicking channel scaffolds.
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Illustrations of the flow experiment for all five test cases.
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Experimental flow mechanics, pressure (blue) and flow rate (red) analysis of the (A) clean 
artery control, (B) large channel models and (D) small channel models placed in a straight 
pipe and (C) large channel models and (E) small channel models placed in a curved pipe. All 
values are normalized for comparison, and are not the true measured experimental values.
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(A) hMSC adhesion on 3D printed scaffolds; data are mean ± standard error of the mean, n 
= 9; *p < 0.05 when compared to scaffolds with 250 μm microchannels and with 500 μm 
microchannels and nHA. (B) Improved hMSC proliferation on 3D printed scaffolds with 
nHA and small microchannels; data are mean ± standard error of the mean, n = 9; #p < 0.01 
when compared to all other scaffolds at day 5 and ##p < 0.05 when compared to 500 and 
250 μm microchannels without nHA; ^p < 0.05 when compared to scaffolds with 500 μm 
microchannels and nHA at day 3; and *p < 0.05 when compared to scaffolds with 250 μm 
microchannels at day 1.
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Confocal microcopy images of 1 d hMSC growth on scaffolds with (A) 500 μm 
microchannels, (B) 250 μm microchannels, (E) 500 μm microchannels + nHA, (F) 250 μm 
microchannels + nHA, and 3 and 5 d hMSC growth on scaffolds with (C) and (D) 250 μm 
microchannels and (E) and (F) 250 μm microchannels + nHA.
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HUVEC adhesion; data are mean ± standard error of the mean, n = 9; *p < 0.05 when 
compared to scaffolds with 250 μm microchannels. HUVEC proliferation on 3D printed 
scaffolds; data are mean ± standard error of the mean, n = 9; *p < 0.05 when compared to all 
other scaffolds at day 5; and ^p < 0.05 when compared to scaffolds with 500 μm 
microchannels and 250 μm microchannels with nHA at day 3.
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Confocal microcopy images of 1 d HUVEC growth on scaffolds with (A) 500 μm 
microchannels, (B) 250 μm microchannels, (E) 500 μm microchannels + nHA and VEGF, 
(F) 250 μm microchannels + nHA and VEGF. 3 and 5 d HUVEC growth on scaffolds with 
(C) and (D) 500 μm microchannels and (G) and (H) 250 μm microchannels + nHA + VEGF.
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(A) Enhanced type I collagen synthesis on microvascular nHA modified scaffolds after 3 
weeks. Data are mean ± standard error of the mean, n = 9; *p < 0.01 when compared to 
scaffolds with 500 and 250 μm microchannels at week 1; **p < 0.05 when compared to 
scaffolds with 500 μm microchannels at week 1; ^p < 0.05 when compared to all other 
scaffolds at week 2; #p < 0.05 when compared to scaffolds with 500 μm microchannels at 
week 3. (B) Enhanced calcium deposition on microvascular nHA modified scaffolds after 3 
weeks. Data are mean ± standard error of the mean, n = 9; *p < 0.05 when compared to 3D 
printed bone scaffolds with 500 and 250 μm microchannels at week 3; **p < 0.05 when 
compared to 3D printed bone scaffolds with 500 μm microchannels at week 3; #p < 0.01 
when compared to all other scaffolds at week 2.
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Table 1
A table of computed and measured scaffold physical attributes.
Parameters Measure methods 500 μm 250 μm
Porosity (%) Computed value 41 42
SEM measure 50 52
Volume (mm3) Computed value 117 105
SEM measure 133 104
Surface area (mm2) Computed value 3400 3014
SEM measure 3407 2672
Surface area/volume ratio (mm−1) Computed value 29 29
SEM measure 26 26
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